Rubella Virus Vaccine Live (MERUVAX II)
Rubella Virus Vaccine Live is an FDA-licensed reference biologic from Merck Sharp & Dohme LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1969
Reference approved
Reference product
MERUVAX II Rubella Virus Vaccine Live
Merck Sharp & Dohme LLC
- Approved
- Jun 09, 1969
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Rubella Virus Vaccine Live, in chronological order.
Reference approval
Approval date of the reference Rubella Virus Vaccine Live product.
57 yr 10 mo ago
Frequently asked questions
Are there biosimilars approved for Rubella Virus Vaccine Live (MERUVAX II)?
No 351(k) biosimilars or interchangeable biosimilars referencing Rubella Virus Vaccine Live are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.